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Abstract
Background—Pulmonary tuberculosis contributes to increased morbidity and mortality in 
severely malnourished children in endemic settings. Despite high clinical suspicion, few 
tuberculosis prevalence estimates exist in malnourished African children. Diagnostics such as 
Xpert MTB/RIF may help to determine pulmonary tuberculosis prevalence, however its 
performance in severely malnourished children is largely unknown.
Methods—We conducted a cross-sectional observational study evaluating Xpert compared to 
smear microscopy and liquid culture on induced sputums among severely malnourished children 
(aged 6 to 60 months) at Kamuzu Central Hospital in Lilongwe, Malawi. From February 1 to May 
30, 2012, children who met World Health Organization 2006 guidelines for severe acute 
malnutrition were evaluated using clinical symptoms, tuberculin skin tests, chest radiographs, and 
induced sputums. National Institute of Health (NIH) consensus case definitions were used to 
estimate tuberculosis prevalence.
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Results—Three hundred severely malnourished children (median age 18.5 months, IQR 
12.1-25.6) had one induced sputum performed; 295 (98.3%) received two. Fifty-two (17.6%) were 
HIV-infected. Over 25% had tuberculosis exposure with 48/297 (16.2%) reporting contact and 
40/287 (13.9%) with positive TST. Two (0.7%) patients had confirmed tuberculosis by Xpert and 
culture, but only one had positive smear microscopy. Twenty (6.7%) patients fulfilled probable 
and 97 (66%) met possible tuberculosis NIH case definitions. Overall mortality was 9.7%.
Conclusions—Microbiologic confirmation likely underestimates the prevalence of pulmonary 
tuberculosis in severely malnourished children. In our study, Xpert on induced sputums did not 
increase case finding. Future studies are needed using Xpert among targeted groups of severely 
malnourished children and on non-sputum specimens.
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BACKGROUND
Of the nearly nine million annual tuberculosis diagnoses, one quarter occur in Africa, with 
approximately 530,000 in children.(1) Pediatric tuberculosis diagnosis is challenging due to 
protean presentation, sample collection difficulties, paucibacilliary disease and limited 
availability of microbiologic culture.(2) Malnourished children are at increased risk of 
tuberculosis infection, disease progression and worse outcomes.(3) HIV further increases 
mortality in this highly vulnerable group.(4,5) Nevertheless, few tuberculosis prevalence 
estimates exist in malnourished African children.(4,6–8)
The complex triad of HIV, tuberculosis and malnutrition exists in Malawi where 
approximately 180,000 children are HIV-infected and mortality among HIV-infected 
malnourished children is high.(5) Children account for 11% of new tuberculosis diagnoses 
annually (Malawi National Tuberculosis Program, unpublished).
Xpert MTB/RIF® (Xpert, Cepheid, Sunnyvale, CA) is a polymerase chain reaction-based 
rapid tuberculosis diagnostic test and the World Health Organization (WHO) recommends 
its use in children suspected of tuberculosis.(9) In 2012, the WHO began reporting global 
pediatric tuberculosis incidence, however improved estimates are needed.(1) Testing 
induced sputums of high-risk children with Xpert may help determine pulmonary 
tuberculosis prevalence in high-HIV burden areas, and better target treatment.(10–14) 
Xpert’s performance in severely malnourished children is largely unknown.
We aimed to determine pulmonary tuberculosis prevalence among hospitalized severely 
malnourished Malawian children with Xpert compared to smear and culture on induced 
sputums, and characterize patients by National Institutes of Health (NIH) consensus case 
definitions (Supplement 1).(15) We hypothesized that severely malnourished children would 
have a high tuberculosis prevalence and Xpert would be superior to smear and similar to 
culture on induced sputums.
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We conducted a cross-sectional study at Kamuzu Central Hospital, a tertiary referral center 
serving central Malawi, from February 1-May 30, 2012. Enrollees met WHO severe acute 
malnutrition criteria for children aged 6–60 months with: weight-for-height z-score ≤-3 
standard deviations below the median, mid-upper arm circumference (MUAC) ≤115mm, or 
bilateral pedal edema.(16) Weight-for-height was not calculated in children with edema 
since this falsely elevates weight. We excluded patients already receiving tuberculosis 
treatment, those with conditions (besides malnutrition) causing edema, and if induced 
sputums were contraindicated.
After informed consent was obtained from a guardian, a tuberculin skin test (TST, 
Tubersol®, Sanofi Pasteur, Swiftwater, PA) and anterior-posterior and lateral digital chest 
radiograph were performed. Radiographs were read by two blinded reviewers per a 
standardized protocol, with discrepant reads adjudicated for final consensus.(15) TST of 
≥5mm was considered positive. Children with unknown HIV-status were tested per Malawi 
protocols. Children were evaluated for the presence of tuberculosis-associated sign/
symptoms according to NIH guidelines, including: fever (>1 week), cough (>2 weeks not 
antibiotic responsive), and lethargy/decreased playfulness (Supplement 1).(15) All children 
met NIH weight loss criteria.
Induced sputums were performed after a 2–3 hour fast with a second sputum collected ≥4 
hours later.(14) Each sample was evaluated by AFB smear/liquid culture (BACTEC MGIT, 
Becton Dickinson, Franklin Lakes, NJ) and Xpert in an internationally accredited research 
laboratory (University of North Carolina Project). Anti-tuberculosis treatment initiation was 
made in conjunction with hospital staff and prescribed per Malawian national guidelines. All 
children were scheduled for six weeks clinical follow-up. Children were clinically improved 
if they had symptom resolution and improvement in weight-for-height, edema, or MUAC.
Each subject was assigned a final NIH clinical case diagnosis of confirmed, probable, 
possible, or unlikely tuberculosis (Supplement 1). These guidelines combine microbiologic 
confirmation, tuberculosis signs/symptoms, chest radiograph, tuberculosis exposure, TST, 
and/or treatment response if applicable.(15)
Statistical Analysis
Categorical data were summarized as proportions and non-normally distributed continuous 
variables were summarized by median and interquartile range. Prevalence ratios (PR) were 
calculated with two-sided tests and 95% confidence intervals. EpiInfo™ (version 7, Atlanta, 
GA) was used to calculate weight-for-height z-scores. SPSS (IBM, version 19.0, Chicago, 
IL) was for all other statistical analysis. For sensitivity analysis, culture was considered the 
gold standard.
Ethical consideration
This study was approved by the Malawi National Health Sciences Research Committee and 
the University of North Carolina Institutional Review Board.
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We enrolled 300 severely malnourished children with a median age of 18.5 months 
(Supplement 2). Median weight-for-height z-score was −2.9; 64.3% (193) had a MUAC 
≤115mm, while 57.7% (173) had bilateral pedal edema. Fifty-two (52/295, 17.6%) patients 
were HIV-infected, with 36.5% (19/52) new diagnoses and 28.8% (15/52) on anti-
retrovirals. Twelve percent (35/295) were HIV-exposed (Supplement 2). Most patients had 
received Bacillus Calmette–Guérin vaccine (292/297, 98.3%).
All patients were assessed for tuberculosis signs/symptoms; 12% (36/300) had cough >2 
weeks not antibiotic-responsive, while 26% (78/300) had fever >1 week (Supplement 2). 
Reduced playfulness/lethargy was reported in 90% (269/299). A tuberculosis contact was 
reported by 16.2% (48/297). TST was positive in 13.9% (40/287) and 3.1% (9/287) had both 
a reported contact and positive TST. Only one child previously received isoniazid. Sixteen 
percent (48/299) of radiographs were interpreted as certain tuberculosis. All participants 
received at least one induced sputum, and 295 (98.3%) received two. Most were performed 
the next day.
Two (0.7%) patients were categorized as confirmed tuberculosis, both with positive Xpert 
and culture, but only one with positive smear microscopy (Supplement 1). One patient had a 
positive Xpert result (including rifampin resistance) but negative smear and culture. Repeat 
Xpert testing of the same specimen was negative, thus it was considered a false positive. 
Twenty (6.7%) patients met NIH definitions for probable, 197 (65.7%) possible and 81 
(27%) unlikely tuberculosis.
Anti-tuberculosis therapy was prescribed to 44% (132/300) (Supplement 2). Of the treated 
patients who followed up, the majority (44/58, 75.9%) had symptom resolution and 
improvement in anthropometric measurements.
Inpatient mortality was 9.3% (28/300), with one additional child dying before follow-up 
(Supplement 2). A significantly higher proportion of deaths occurred among HIV-infected 
(11/52, 21.1%) compared to HIV-unexposed children (14/208, 6.7%) (PR 3.1 95% CI 1.5–
6.5, p=0.0016). The prevalence of death among HIV-exposed (2/35, 5.7%) and HIV-
unexposed children was similar (PR 0.8 95% CI 0.2–3.6, p=0.82).
Xpert’s sensitivity compared to liquid culture was 100% with 2 of 2 cases identified (95% 
CI 15.8–100.0), with 99.7% specificity (297/298, 95% CI 98.1–100.0). Smear microscopy 
sensitivity was 50% (1/2 cases, 95% CI 1.3–98.7) with 100% specificity (298/298, 95% CI 
98.8–100.0).
DISCUSSION
Malnutrition is a major cause of morbidity and mortality among African children. Although 
tuberculosis is thought to be a major contributor, there are few prevalence estimates in 
malnourished children. We consecutively screened 300 severely malnourished hospitalized 
Malawian children for pulmonary tuberculosis using Xpert and NIH guidelines. We found 
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only two culture-confirmed tuberculosis cases (both detected by Xpert) but a relatively high 
proportion of tuberculosis exposure (26.3%) and probable tuberculosis cases (6.7%).
Sputum culture is positive in only 30–62% of clinically diagnosed pediatric pulmonary 
tuberculosis cases.(17) Among previous pediatric Xpert studies, culture positivity ranged 
from 8–23% among tuberculosis suspects, with Xpert sensitivity of 57–79% versus culture.
(10–14) Children in these studies were less malnourished with median weight-for-height or 
weight-for-age z-score of −1.9–0.2. Our lower culture positivity rate likely underestimates 
the true prevalence of pulmonary tuberculosis in this group of severely malnourished 
children, given the high frequencies of tuberculosis-associated signs/symptoms, positive 
TSTs, tuberculosis contacts, tuberculosis consistent radiographs and clinical improvement 
with treatment. Over 25% of our patients had tuberculosis exposure (contact and/or positive 
TST), which is associated with high risk of developing tuberculosis disease in children.
(2,18) Anti-tuberculosis therapy was prescribed to 44% of our patients, similar to previous 
pediatric Xpert studies, illustrating a high clinical concern for pulmonary tuberculosis 
disease even among those children without microbiologic confirmation.(10–14)
The prevalence of NIH-defined probable and confirmed tuberculosis was 7.3%, which likely 
more accurately reflects the burden of tuberculosis than culture-confirmation alone. 
Potential reasons for our lower rates of culture confirmation may be due to more prevalent 
paucibacillary pulmonary disease, extrapulmonary or disseminated disease not detected on 
induced sputum samples. Our estimates were lower compared to the 19–22% prevalence of 
clinically diagnosed tuberculosis (not culture-confirmed), among severely malnourished 
hospitalized children in South Africa, Malawi and India, likely due to our use of more 
stringent NIH definitions.(4,6,15,19)
This study’s limitations include high lost to follow-up that may have biased treatment 
response and mortality results, although it did not influence inpatient measures. Our research 
occurred at a single site which may limit generalizability, although malnourished children 
receive similar care in nutritional rehabilitation units throughout Malawi. Low microbiologic 
confirmation may have been due to sample collection or lab processing error, however this 
is unlikely as protocols provided from previous pediatric Xpert trials were followed closely 
and testing occurred in our internationally accredited lab.
In summary, our study demonstrated high tuberculosis prevalence in severely malnourished 
children per NIH definitions, but low rates of Xpert or culture-confirmed on induced 
sputums. Given Xpert and culture did not contribute to additional case finding, our data does 
not support routine screening of hospitalized severely malnourished children in Malawi 
using Xpert or culture on induced sputum. Xpert may have increased utility among targeted 
malnourished children, or on different specimens such as stool, urine or blood. Therefore, 
we recommend continued clinical tuberculosis screening with a low treatment threshold in 
severely malnourished hospitalized children suspected of tuberculosis. Additional findings 
of high HIV prevalence, high proportion of new HIV diagnosis, and low isoniazid 
preventive therapy suggest important operational gaps.
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